WALTHAM, Mass, Dec. 6, 2019 /PRNewswire/ — BVI, one of the fastest growing diversified companies in ophthalmology, today announced it has acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicon oils, gases and perfluorocarbons used in vitreoretinal surgery.
Growth of the Arcad products will be accelerated through BVI’s broad-reaching commercial infrastructure established with the Vitreq line of vitreoretinal surgical products.